Sionna Therapeutics, Inc.
USD42.97
+0.79 (+1.87%)
CEO
Michael Cloonan
IPO Date
2025-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$42.23
Prev. Close
$42.18
Day Low
$42.16
Day High
$43.48
52W Low
$15.10
52W High
$48.45
Market Cap
$1.94B
Volume
0.30M
| 17,340 |
| $36.73 |
| 18 Jun 2026 | Thompson Peter A. | director | A-Award | Acquired | 17,340 | $36.73 |
| 18 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 17,340 | $36.73 |
| 18 Jun 2026 | Ruddy Marcella K. | director | A-Award | Acquired | 17,340 | $36.73 |
| 18 Jun 2026 | Resnick Joshua | director | A-Award | Acquired | 17,340 | $36.73 |
| 18 Jun 2026 | Fleming Harold Edward | director | A-Award | Acquired | 17,340 | $36.73 |
| 18 Jun 2026 | Clancy Paul J | director | A-Award | Acquired | 17,340 | $36.73 |
| 18 Jun 2026 | Booth Bruce | director | A-Award | Acquired | 17,340 | $36.73 |
| 29 May 2026 | Thompson Peter A. | director | S-Sale | Disposed | 101 | $44.49 |